Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16.

Zappa, Martina; Verdecchia, Paolo; Angeli, Fabio

Zappa, Martina; Verdecchia, Paolo; Angeli, Fabio.

Zappa M; Department of Medicine and Surgery, University of Insubria - Varese, Italy.
Verdecchia P; Fondazione Umbra Cuore e Ipertensione-ONLUS and Division of Cardiology, Hospital S. Maria della Misericordia, Perugia, Italy.
Angeli F; Dipartimento di Medicina e Innovazione Tecnologica (DiMIT), University of Insubria - Varese, Italy; Department of Medicine and Cardiopulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, Italy. Electronic address: fabio.angeli@uninsubria.it.

Eur J Intern Med ; 113: 13-15, 2023 Jul.

Article in English | MEDLINE | ID: covidwho-2306318

Subject(s)

COVID-19; SARS-CoV-2; Humans; Pandemics; Renin-Angiotensin System; Peptidyl-Dipeptidase A/metabolism

Keywords

COVID-19; Evolution; Mutations; Renin angiotensin system; SARS-CoV-2; Spike protein; XBB.1.16

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Topics: Variants Limits: Humans Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2023 Document Type: Article Affiliation country: J.ejim.2023.04.016

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google